Viraemic-time predicts mortality among people living with HIV on second-line antiretroviral treatment in Myanmar: A retrospective cohort study.
Anita MesicTom DecrooHtay Thet MarBart K M JacobsMoe Pyae ThandarThin Thin ThweAung Aung KyawMitchell SangmaDavid BeversluisElkin Bermudez-AzaAlexander SpinaDarli Po Po AungErwan PiriouKoert RitmeijerJosefien Van OlmenHtun Nyunt OoLutgarde LynenPublished in: PloS one (2022)
Key populations were at risk for having a higher viraemic-time on second-line ART. Viraemic-time predicts clinical outcomes. Differentiated services should target subgroups at risk for a higher viraemic-time to control both HIV transmission and mortality.